Please select the option that best describes you:
Do you cap cisplatin dose in obese patients undergoing chemotherapy in germ cell tumors?
Do you cap BSA at 2 or 2.2 for such patients to prevent Cisplatin neuropathy and CKD?
Do you cap BSA at 2 or 2.2 for such patients to prevent Cisplatin neuropathy and CKD?